The Patent Finder

IGISU Co., Ltd.

10 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
5
Ending by 2030
Jul 2030
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 21, 2027.

Recent changes

  • 1 term has ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,358,269Method for treating dermatitis and improving skin texture using natriuretic peptides
In force
 · USPTO record
In forceUSPTO record
US 9,968,654Method of treatment dermatitis with c-type natriuretic peptide derivatives
In force
 · USPTO record
In forceUSPTO record
US 10,946,072Method for treating dermatitis and improving skin texture using B-type natriuretic peptides
In force
 · USPTO record
In forceUSPTO record
US 9,358,270Method of Treating Rhinitis with B-Type and C-Type Natriuretic Peptides
In force
 · High confidence
In forceHigh confidence
US 9,962,429Method for Treating Rhinitis with B and C-Type Natriuretic Peptide Containing Chimeric Ring Structures
In force
 · High confidence
In forceHigh confidence
US 9,480,728Agent for the treatment of alopecia
In force
 · USPTO record
In forceUSPTO record
US 9,808,511Method for treating alopecia with B-type natriuretic peptide
In force
 · USPTO record
In forceUSPTO record
US 11,571,464C-Type Natriuretic Peptide Agent for the Treatment of Alopecia
In force
 · Low confidence
In forceLow confidence
US 12,221,495Cyclic peptide and a medicament, external preparation and cosmetic comprising said cyclic peptide
In force
 · USPTO record
In forceUSPTO record
US 12,065,512Cyclic peptide and a medicament, external preparation and cosmetic comprising said cyclic peptide
In force
 · USPTO record
In forceUSPTO record
Also on record, not counted in the 10: 1 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 1 abandoned · 2 no status recorded

Showing 1 to 5 of 5, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/626,956CNP Cyclic Peptide, and Medicine, External Preparation and Cosmetic Each Containing Said Cyclic PeptideApr 4, 2024Pending
15/749,275CNP Cyclic Peptide, and Medicine, External Preparation and Cosmetic Each Containing Said Cyclic PeptideAug 1, 2016Pending
13/355,484Jan 21, 2012No status recorded
13/392,657Therapeutic Agent for RhinitisAug 27, 2010Abandoned
13/386,528Jul 23, 2010No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited